世界卫生组织呼吁迅速报告和公开干预性临床试验结果这一新立场的基本原理。
Rationale for WHO's new position calling for prompt reporting and public disclosure of interventional clinical trial results.
作者信息
Moorthy Vasee S, Karam Ghassan, Vannice Kirsten S, Kieny Marie-Paule
机构信息
World Health Organization, Geneva, Switzerland.
出版信息
PLoS Med. 2015 Apr 14;12(4):e1001819. doi: 10.1371/journal.pmed.1001819. eCollection 2015 Apr.
Abstract
Vasee Moorthy and colleagues explain why the WHO is calling for public disclosure of clinical trial results.
摘要
瓦西·穆尔蒂及其同事解释了世界卫生组织呼吁公开临床试验结果的原因。
相似文献
1
Rationale for WHO's new position calling for prompt reporting and public disclosure of interventional clinical trial results.世界卫生组织呼吁迅速报告和公开干预性临床试验结果这一新立场的基本原理。
PLoS Med. 2015 Apr 14;12(4):e1001819. doi: 10.1371/journal.pmed.1001819. eCollection 2015 Apr.
2
Who will implement WHO's statement on public disclosure of trial results?谁将执行世界卫生组织关于公开试验结果的声明？
Lancet. 2015 Jun 13;385(9985):2353-4. doi: 10.1016/S0140-6736(15)61100-X.
3
[Moving toward the reduction of publication/reporting biases in clinical trials using a new international standard].[采用新的国际标准减少临床试验中的发表/报告偏倚]
Nihon Koshu Eisei Zasshi. 2016;63(10):599-605. doi: 10.11236/jph.63.10_599.
4
Beyond trial registration: a global trial bank for clinical trial reporting.超越试验注册：建立全球临床试验报告库。
PLoS Med. 2005 Nov;2(11):e365. doi: 10.1371/journal.pmed.0020365. Epub 2005 Oct 18.
5
How to get all trials reported: audit, better data, and individual accountability.如何让所有试验都得到报告：审核、更好的数据以及个人问责制。
PLoS Med. 2015 Apr 14;12(4):e1001821. doi: 10.1371/journal.pmed.1001821. eCollection 2015 Apr.
6
The WHO International Clinical Trials Registry Platform: relevance to the Indian register of clinical trials.世界卫生组织国际临床试验注册平台：与印度临床试验注册的相关性。
Natl Med J India. 2006 May-Jun;19(3):161-4.
7
Are Pseudonyms Ethical in (Science) Publishing? Neuroskeptic as a Case Study.笔名在（科学）出版界是否合乎道德规范？以“神经质疑者”为例。
Sci Eng Ethics. 2017 Dec;23(6):1807-1810. doi: 10.1007/s11948-016-9825-7. Epub 2016 Nov 9.
8
Informed consent: time for more transparency.知情同意：是时候提高透明度了。
Arthritis Res Ther. 2010;12(3):121. doi: 10.1186/ar3004. Epub 2010 Jun 3.
9
One of a kind--the Pan African Clinical Trials Registry, a regional registry for Africa.独一无二——泛非临床试验注册中心，非洲的一个地区性注册机构。
Pan Afr Med J. 2011;9:42. doi: 10.4314/pamj.v9i1.71221. Epub 2011 Aug 23.
10
Delays in reporting and publishing trial results during pandemics: cross sectional analysis of 2009 H1N1, 2014 Ebola, and 2016 Zika clinical trials.大流行期间临床试验结果报告和发表的延迟：对 2009 年 H1N1、2014 年埃博拉和 2016 年寨卡临床试验的横断面分析。
BMC Med Res Methodol. 2021 Jun 8;21(1):120. doi: 10.1186/s12874-021-01324-8.
引用本文的文献
1
A cross-sectional study on the endorsement of reporting guidelines and clinical trial registration among immunology and allergy journals.一项关于免疫学和过敏学期刊对报告指南及临床试验注册认可情况的横断面研究。
PLoS One. 2025 May 7;20(5):e0322003. doi: 10.1371/journal.pone.0322003. eCollection 2025.
2
CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials.CONSORT 2025解释与阐述：随机对照试验报告的更新指南
BMJ. 2025 Apr 14;389:e081124. doi: 10.1136/bmj-2024-081124.
3
Globalisation of clinical trials in oncology: a double-edged sword?肿瘤学临床试验的全球化：一把双刃剑？
BMJ Oncol. 2023 Sep 30;2(1):e000163. doi: 10.1136/bmjonc-2023-000163. eCollection 2023.
4
Time to publication for results of clinical trials.临床试验结果的发表时间。
Cochrane Database Syst Rev. 2024 Nov 27;11(11):MR000011. doi: 10.1002/14651858.MR000011.pub3.
5
Effectiveness of early pharmaceutical interventions in symptomatic COVID-19 patients: A randomized clinical trial.早期药物干预对有症状的COVID-19患者的有效性：一项随机临床试验。
Pak J Med Sci. 2024 May-Jun;40(5):800-810. doi: 10.12669/pjms.40.5.8757.
6
Time to Publication and Time-Lag Publication Bias for Randomized Trials on Connective Tissue Diseases.结缔组织疾病随机试验的发表时间和时间滞后发表偏倚。
ACR Open Rheumatol. 2023 Aug;5(8):420-425. doi: 10.1002/acr2.11582. Epub 2023 Jul 13.
7
CoVigator-A Knowledge Base for Navigating SARS-CoV-2 Genomic Variants.CoVigator- 用于导航 SARS-CoV-2 基因组变异的知识库。
Viruses. 2023 Jun 17;15(6):1391. doi: 10.3390/v15061391.
8
Time from submission to publication in urology journals: A look at publication times before and during Covid-19.从投稿到在泌尿外科期刊发表的时间：审视新冠疫情之前及期间的发表时间
Heliyon. 2023 Mar 2;9(3):e14233. doi: 10.1016/j.heliyon.2023.e14233. eCollection 2023 Mar.
9
Publication bias in trials registered in the Australian New Zealand Clinical Trials Registry: Is it a problem? A cross-sectional study.澳大利亚新西兰临床试验注册中心注册试验中的发表偏倚：这是一个问题吗？一项横断面研究。
PLoS One. 2023 Jan 5;18(1):e0279926. doi: 10.1371/journal.pone.0279926. eCollection 2023.
10
CTO: a Community-Based Clinical Trial Ontology and its Applications in PubChemRDF and SCAIView.CTO：一种基于社区的临床试验本体及其在PubChemRDF和SCAIView中的应用。
CEUR Workshop Proc. 2020 Sep;2807.
本文引用的文献
1
[Recommendations for the conduct, reporting, editing and publication of scholarly work in medical journals].[关于医学期刊中学术作品的撰写、报告、编辑及发表的建议]
Zhonghua Gan Zang Bing Za Zhi. 2014 Oct;22(10):781-91.
2
Extent of non-publication in cohorts of studies approved by research ethics committees or included in trial registries.经研究伦理委员会批准或纳入试验注册的研究队列中的未发表情况。
PLoS One. 2014 Dec 23;9(12):e114023. doi: 10.1371/journal.pone.0114023. eCollection 2014.
3
Sharing and reporting the results of clinical trials.分享和报告临床试验结果。
JAMA. 2015 Jan 27;313(4):355-6. doi: 10.1001/jama.2014.10716.
4
How frequently do the results from completed US clinical trials enter the public domain?--A statistical analysis of the ClinicalTrials.gov database.已完成的美国临床试验结果多久进入公共领域？——对ClinicalTrials.gov数据库的统计分析。
PLoS One. 2014 Jul 15;9(7):e101826. doi: 10.1371/journal.pone.0101826. eCollection 2014.
5
Non-publication and delayed publication of randomized trials on vaccines: survey.疫苗随机试验的未发表和延迟发表：调查。
BMJ. 2014 May 16;348:g3058. doi: 10.1136/bmj.g3058.
6
Non-publication of large randomized clinical trials: cross sectional analysis.大型随机临床试验未发表结果的分析：横断面研究。
BMJ. 2013 Oct 29;347:f6104. doi: 10.1136/bmj.f6104.
7
World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.《世界医学协会赫尔辛基宣言：涉及人类受试者的医学研究伦理原则》
JAMA. 2013 Nov 27;310(20):2191-4. doi: 10.1001/jama.2013.281053.
8
Selective publication of antidepressant trials and its influence on apparent efficacy.抗抑郁药物试验的选择性发表及其对表面疗效的影响。
N Engl J Med. 2008 Jan 17;358(3):252-60. doi: 10.1056/NEJMsa065779.
9
Underreporting research is scientific misconduct.隐瞒研究成果属于科研不端行为。
JAMA. 1990 Mar 9;263(10):1405-8.
Zotero 插件